Insider trade

UiPath (PATH): CEO sold ~$551K

Daniel Dines, CEO at UiPath, sold ~$551K of UiPath shares.

~$551K
Approx. value · 45K sh @ $12.25
4.74M
Holds after · shares reported
Traded
Jul 25, 2025
Filed
Jul 25, 2025

What stands out in this filing

  • The sale was 0.9% of the shares this insider held before it; the filing reports 4,743,376 shares, held indirectly afterwards.
  • 45,000 shares at an average of $12.25 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 20, 2025InsiderCEO sold ~$556K of PATH shares in the open market
  2. Jun 23, 2025InsiderCEO sold ~$544K of PATH shares in the open market
  3. Jun 24, 2025InsiderCEO sold ~$562K of PATH shares in the open market
  4. Jun 25, 2025InsiderCEO sold ~$565K of PATH shares in the open market
  5. Jun 26, 2025InsiderCEO sold ~$557K of PATH shares in the open market
  6. Jun 27, 2025InsiderCEO sold ~$575K of PATH shares in the open market
  7. Jun 30, 2025InsiderCEO sold ~$575K of PATH shares in the open market
  8. Jul 1, 2025InsiderCEO sold ~$578K of PATH shares in the open market
  9. Jul 2, 2025Insider · 2 peopleInsiders: 2 sales (~$1.3M)
  10. Jul 3, 2025InsiderCEO sold ~$586K of PATH shares in the open market
  11. Jul 7, 2025InsiderCEO sold ~$590K of PATH shares in the open market
  12. Jul 8, 2025InsiderCEO sold ~$595K of PATH shares in the open market
  13. Jul 9, 2025InsiderCEO sold ~$593K of PATH shares in the open market
  14. Jul 10, 2025InsiderCEO sold ~$588K of PATH shares in the open market
  15. Jul 11, 2025InsiderCEO sold ~$572K of PATH shares in the open market
  16. Jul 14, 2025InsiderCEO sold ~$560K of PATH shares in the open market
  17. Jul 15, 2025InsiderCEO sold ~$563K of PATH shares in the open market
  18. Jul 16, 2025InsiderCEO sold ~$559K of PATH shares in the open market
  19. Jul 17, 2025InsiderCEO sold ~$560K of PATH shares in the open market
  20. Jul 18, 2025InsiderCEO sold ~$557K of PATH shares in the open market
  21. Jul 21, 2025InsiderCEO sold ~$572K of PATH shares in the open market
  22. Jul 22, 2025InsiderCEO sold ~$561K of PATH shares in the open market
  23. Jul 23, 2025InsiderCEO sold ~$565K of PATH shares in the open market
  24. Jul 24, 2025InsiderCEO sold ~$565K of PATH shares in the open market
  25. Jul 25, 2025 · this disclosureInsiderCEO sold ~$551K of PATH shares in the open market

What came next

  1. Jul 28, 2025InsiderCEO sold ~$547K of PATH shares in the open market
  2. Jul 29, 2025InsiderCEO sold ~$549K of PATH shares in the open market
  3. Jul 30, 2025InsiderCEO sold ~$543K of PATH shares in the open market
  4. Jul 31, 2025InsiderCEO sold ~$120K of PATH shares in the open market
  5. Sep 10, 2025InsiderCEO sold ~$540K of PATH shares in the open market
  6. Sep 17, 2025InsiderCEO sold ~$1.44M of PATH shares in the open market
  7. Sep 18, 2025InsiderCEO sold ~$1.46M of PATH shares in the open market
  8. Sep 19, 2025InsiderCEO sold ~$1.46M of PATH shares in the open market
  9. Sep 22, 2025InsiderCEO sold ~$1.5M of PATH shares in the open market
  10. Sep 23, 2025InsiderCEO sold ~$1.59M of PATH shares in the open market
  11. Sep 24, 2025InsiderCEO sold ~$1.53M of PATH shares in the open market
  12. Sep 25, 2025InsiderCEO sold ~$1.47M of PATH shares in the open market
  13. Sep 26, 2025InsiderCEO sold ~$1.48M of PATH shares in the open market
  14. Sep 29, 2025InsiderCEO sold ~$1.51M of PATH shares in the open market
  15. Sep 30, 2025InsiderCEO sold ~$1.82M of PATH shares in the open market
  16. Oct 6, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
  17. Oct 7, 2025InsiderCEO sold ~$1.84M of PATH shares in the open market
  18. Oct 8, 2025InsiderCEO sold ~$1.83M of PATH shares in the open market
  19. Oct 9, 2025Insider · 2 peopleInsiders: 4 sales (~$6.2M)
  20. Oct 10, 2025InsiderCEO sold ~$2.25M of PATH shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for UiPath

For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PATH page.

Other recent filings by Daniel Dines, CEO and Chairman

The full history of Daniel Dines, CEO and Chairman is on the profile page.

How this filing works

Explore the data

Common questions

Which UiPath (PATH) insider traded, and how much?

Daniel Dines, CEO at UiPath, sold ~$551K of UiPath shares. 45K shares at $12.25.

When did it happen, and when was it made public?

Traded: Jul 25, 2025. Filed: Jul 25, 2025.

What stands out in this filing?

The sale was 0.9% of the shares this insider held before it; the filing reports 4,743,376 shares, held indirectly afterwards. 45,000 shares at an average of $12.25 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about UiPath recently?

For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the PATH page.

Does this mean PATH stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at UiPath

Everything OQRO holds on this company is on its PATH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data